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Abstract
Background: The matrix 1 (M1) protein of Influenza A virus plays many critical roles throughout the virus life cycle. The
oligomerization of M1 is essential for the formation of the viral matrix layer during the assembly and budding process.
Methodology/Principal Findings: In the present study, we report that M1 can oligomerize in vitro, and that the
oligomerization is pH-dependent. The N-terminal domain of M1 alone exists as multiple-order oligomers at pH 7.4, and the
C-terminal domain alone forms an exclusively stable dimer. As a result, intact M1 can display different forms of oligomers
and dimer is the smallest oligomerization state, at neutral pH. At pH 5.0, oligomers of the N-terminal domain completely
dissociate into monomers, while the C-terminal domain remains in dimeric form. As a result, oligomers of intact M1
dissociate into a stable dimer at acidic pH.
Conclusions/Significance: Oligomerization of M1 involves both the N- and C-terminal domains. The N-terminal domain
determines the pH-dependent oligomerization characteristic, and C-terminal domain forms a stable dimer, which
contributes to the dimerization of M1. The present study will help to unveil the mechanisms of influenza A virus assembly
and uncoating process.
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Introduction
Influenza viruses are enveloped viruses that belong to the
Orthomyxovirus family. The genome of influenza A virus contains
eight negative-stranded RNA segments, which code for 10 or 11
proteins [1,2,3,4,5]. The matrix 1 (M1) protein, encoded by
segment 7, is the most abundant structural protein in the virions
[6,7]. M1 is a multifunctional protein that plays essential roles in
many aspects of the virus life cycle. It forms the matrix layer
localized between the lipid membrane and the viral ribonucleo-
proteins (vRNPs) [8], ensuring the stabilization of the architecture
of the virion. By interacting with RNA and vRNPs [9,10,11], M1
is also involved in nuclear localization [12], RNA transcription
inhibition [13,14,15], and regulation of the import/export of
newly synthesized vRNPs [16,17,18]. As the major structural
protein, M1 plays an important role in virus assembly and
budding. It can form virus-like particles (VLPs) through collabo-
ration with other viral proteins [19,20,21,22]. During budding,
M1 brings viral components to the budding site [23], interacts with
viral envelope proteins (HA, NA, M2) [24,25,26], and also recruits
host components needed for bud completion [24,27,28].
M1 protein is made up of 252 amino acid residues [29], and
consists of two domains (N-terminal domain from 1 to 164 aa and
C-terminal domain from 165 to 252 aa) linked by a protease-
sensitive loop. The three-dimensional structure of the N-terminal
domain was determined by X-ray diffraction at pH 4.0 and
pH 7.0 [30,31,32]. The structures showed that the N-terminal
domain consists of two 4-helix bundles (2 to 67 aa and 91 to 158
aa) connected by a helix linker (H5). The three dimensional
structure of C-terminal domain has not been obtained so far, but
data from circular dichroism (CD), tritium bombardment and
bioinformatics analysis suggest that C-terminal domain folds into
helices and contains an appreciably unstructured region
[30,33,34,35,36].
Previous investigations have also shown that M1 has a strong
tendency to oligomerize [37]. In virus assembly and the budding,
the oligomerization of M1 is required for the matrix layer to form
under the lipid membrane [21,38,39,40,41]. Furthermore, the
M1-M1 interaction facilitates membrane bending, which is
required for bud initiation [38,41]. Expression of M1 alone in
eukaryotic cells allows for the production of VLPs [21,22]. While
in authentic virions, M1 forms an ordered structure adjacent to the
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mediates the oligomerization of M1. The crystal structure of the
N-terminal domain showed that it dimerizes through the
interaction interfaces [31,32], and that the 91–158 aa region is
the main determinant of M1 self-oligomerization [10].
Interestingly, Noton et al. reported that the C-terminal domain
also plays an important role in oligomerization by interacting with
the N-terminal domain, but not with other C-terminal domains
[10]. Furthermore, Ruigrok et al. found that the C-terminal
domain is involved in M1 oligomerization, for the C-terminal
alone could cause aggregation [43]. Studies of the behavior of the
C-terminal domain have produced conflicting results, which lead
to future investigation into fully elucidating the role of C-terminal
domain in M1 oligomerization.
During the uncoating process of virus infection, the virion is
acidified by the influx of H
+ [44,45,46]. A structural transition of
the matrix layer has been observed when the virus was incubated
at low pH [42]. Recent research by cryo-electron tomography
further showed that the intermolecular interactions in the M1
layer are affected when the virions were incubated at pH 4.9, and
the matrix layer was no longer seen in the virions [47]. The
interaction between M1 and vRNP has also been shown to be
disrupted by low pH [9]. Zhirnov found that M1 extracted from
M1-vRNP complexes at an acidic pH is in a monomeric form and
does not aggregate after pH neutralization [9,15]. But the crystal
structure of the N-terminal domain solved by Harris at pH 4.0
suggested that this domain is a dimer [32]. Therefore, it is not
certain which oligomerization state of M1 forms in acidic pH, and
how the influence of pH affects the oligomerization of M1.
In order to resolve these aforementioned issues, we investigated
the oligomerization of M1 and determined the individual
contribution of the N- and C-terminal domains. We found that
the oligomerization of M1 is pH-dependent. M1 can form
multiple-ordered oligomers at neutral pH, and those oligomers
dissociate at acidic pH to dimeric form. Further studies revealed
that pH-dependent oligomerization characteristic of M1 is due to
the N-terminal domain. The C-terminal domain exists as a stable
dimer in solution, independent of pH and concentration.
Results
The oligomerization of M1 is dependent on pH
It has been reported that M1 forms an organized structure
adjacent to the envelope in virus particles [42]. Ruigrok et al.
extracted M1 oligomers from influenza A virus [41] and Zhao et al.
reported that M1 tends to oligomerize soon after synthesis in
BHK-21 cells [48]. To investigate the oligomerization of M1 in
vitro, we constructed recombinant M1 with a C-terminal His6-tag,
which was produced in soluble form in E. coli. M1 was purified by
nickel affinity chromatography and showed a single band at about
28 kDa on SDS-PAGE (Fig. S1A, lane 3). CD spectroscopy
analysis showed that purified M1 was a typical a-helical protein
(Fig. S1B). Consistent with the previous report [32], the result
showed that recombinant M1 was not stable and that the protein
could degrade
Purified M1 from nickel affinity chromatography at a concen-
tration of 0.8 mg/ml was eluted from the gel filtration column in
four major fractions at pH 7.4, whose elution volumes were
8.8 ml, 11.2 ml, 13.5 ml, and 15.8 ml, respectively (Fig. 1A). The
apparent molecular mass of the 15.8-ml fraction was estimated to
be 52 kDa, approximately double of that of the M1 monomer
(28.9 kDa) (Fig. S2). The result indicated that the smallest
oligomerization state of M1 is a dimer. The oligomerization state
of 15.8-ml fraction of M1 was further confirmed by cross linking
assay. After treating with glutaraldehyde, the sample showed two
bands on Tricine-SDS-PAGE. One band was at the same
position with the untreated sample (28 kDa), while the other ran
to the position of about 56 kDa, which is the molecular mass of
an M1 dimer (Fig. 2A). The dimeric M1 eluted from a gel
filtration column was collected and concentrated to different
concentrations by Ultra filtration, and then re-applied to the gel
filtration column at pH 7.4. In this process, M1 exhibited
concentration-dependent oligomerization (Fig. 1B). When the
loaded protein reached a concentration of 0.1 mg/ml, M1 was
eluted from the gel filtration column as a single fraction of
15.8 ml. However, with an increase of protein concentration to
0.5 mg/ml, M1 yielded four fractions with the elution volumes of
10.1 ml, 11.2 ml, 13.5 ml, and 15.8 ml, corresponding to the
molecular masses of 580 kDa, 460 kDa, 155 kDa, and 52 kDa,
respectively. An 8.8-ml fraction was observed on the gel filtration
column when the loaded protein concentration reached 1.0 mg/
ml, indicating M1 is able to form higher molecular mass
oligomers which beyond the detection limits of the column.
The proportion of 10.1-ml, 11.2-ml, and 13.5-ml fractions also
increased with increasing of sample concentration. We further
collected 10.1-ml, 11.2-ml, and 13.5-ml fractions, respectively,
and re-applied the samples to the gel filtration column at pH 7.4.
The proteins continued to elute at the same volumes (Fig. 1D).
Even if the 10.1-ml, 11.2-ml, and 13.5-ml fractions were diluted
to the concentration of 0.05 mg/ml, their elution volumes did not
change and no other oligomerization state formed on the gel
filtration column at pH 7.4 (data not shown). These results
indicated that M1 can form stable oligomers at neutral pH, and
that the oligomerization process is irreversible.
The effect of acidity on oligomerization of M1 was investigated
at pH 5.0. M1 purified by nickel affinity chromatography was
exchanged into a buffer at pH 5.0. 1.0 mg/ml M1 was loaded
onto the gel filtration column, and only the 15.8-ml fraction was
observed (Fig. S3A). The fraction was collected and concentrated
to higher concentrations by ultrafiltration, but it continued to elute
at 15.8 ml on the column (Fig. 1C). The result indicated that the
dimeric protein underwent no detectable oligomerization during
concentration. Furthermore, it was ascertained that increasing the
pH environment of M1 by changing the buffer to pH 7.4 did not
change the oligomerization state of M1. M1 dimer alone was
observed on the gel filtration column after pH neutralization (Fig.
S3C). The pH influence on the high molecular mass oligomers was
also examined. We collected the 10.1-ml, 11.2-ml, and 13.5-ml
fractions from the gel filtration column at pH 7.4 and exchanged
the samples into buffer of pH 5.0. Each sample was loaded on the
column at pH 5.0, and all the samples eluted at 15.8 ml. The
15.8-ml fraction generated from acidification of 11.2-ml fraction
was shown in Fig. 1D. The result indicated the interactions
between dimeric M1 molecules were destroyed by low pH. Taken
together, these results indicated that the oligomerization of M1 is
dependent on pH, and that the dimeric form of M1 is stable at
acidic pH.
The analysis of direct interactions between M1 molecules was
carried out by a GST pull-down assay. We found that hisM1
could bind to GST-M1 (Fig. 2B, lane 3), but not to GST alone at
pH 7.4 (Fig. 2B, lane 2). The hisM1 was pulled down by GST-
M1 at pH 7.4 and was then washed with an acidic buffer
(pH 5.0), but no hisM1 was detected by the anti-His antibody
(Fig. 2B, lane 4). As M1 forms dimers at pH 5.0, this result
indicated that the direct interaction between dimeric M1 could
be inhibited by low pH.
Influenza A Virus M1 Oligomerization
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To determine the roles of the two domains in M1 oligomer-
ization, we further analyzed the oligomerization behavior of the
N-terminal (1–170 aa) and C-terminal (165–252 aa) domains.
Recombinant M1N was constructed with a C-terminal His6-tag
and expressed in soluble form in E. coli. M1N was purified by
nickel affinity chromatography and showed a single band of about
18 kDa on Tricine-SDS-PAGE (Fig. S1A, lane 5). Far-UV CD
spectroscopy showed that the secondary structure of the recom-
binant protein was composed of 72% a-helical and 28% random
coil, which was consistent with the crystal structure (70% a-helical)
(Fig. S1B).
M1N purified by affinity chromatography to 0.9 mg/ml was
loaded onto the gel filtration column at pH 7.4. The sample
yielded five fractions with the elution volumes of 9.8 ml, 11.3 ml,
13.5 ml, 16.0 ml, and 17.6 ml (Fig. 3A). The apparent molecular
mass of the 17.6-ml fraction of M1N was estimated to be 19 kDa,
which is consistent with monomeric M1N (19.8 kDa) (Fig. S2).
Then the protein was concentrated to different concentrations and
re-applied to the gel filtration column. Similar to the intact
protein, M1N also exhibited a concentration-dependent oligomer-
ization. Only a single 17.6-ml fraction was observed on the gel
filtration column when the loaded protein concentration was
0.3 mg/ml. However, the 0.5 mg/ml sample produced five
fractions. The elution volumes of the fractions were 9.8 ml,
11.3 ml, 13.5 ml, 16.0 ml, and 17.6 ml, corresponding to the
molecular masses of 654 kDa, 436 kDa, 169 kDa, 51 kDa, and
19 kDa, respectively. The proportion of the first four oligomer-
ization fractions also increased with increasing sample concentra-
tion (Fig. 3B). When the loaded protein concentration was above
1.0 mg/ml, some of the protein precipitated after incubation at
room temperature for 1 h. Also, we collected 9.8-ml, 11.3-ml, and
13.5-ml fractions individually and re-applied each sample to the
gel filtration column. The elution volumes of the fractions stayed
the same and no other oligomers were observed on the column at
pH 7.4 (Fig. 3D), even when the concentrations of the 9.8-ml,
11.3-ml, and 13.5-ml fractions were diluted to lower than 0.1 mg/
ml (data not shown). The data clearly suggested that, like the intact
M1, the N-terminal domain can form multi-order oligomers at
neutral pH, and that the oligomerization process of M1N is also
irreversible.
Figure 1. The oligomerization of M1 analyzed by gel filtration. The oligomerization of M1 was analyzed on a Superdex 200 HR 10/30 column.
(A) Purified M1 from nickel affinity chromatography yielded four peaks, whose elution volumes are indicated. The samples from each peak were
collected and analyzed by SDS-PAGE. (B) The 15.8-ml fraction (from panel A) was collected, concentrated and re-applied on the gel filtration column
at different concentrations, at pH 7.4. (C) Different concentrations of M1 all eluted as a single peak on the gel filtration column at pH 5.0. (D) Peak 1, 2,
3 correspond to the 10.1-ml, 11.2-ml, and 13.5-ml fractions of M1 re-applied on the gel filtration column at pH 7.4, respectively. Peak 4 corresponds to
the 11.2-ml fraction re-applied on the gel filtration column at pH 5.0.
doi:10.1371/journal.pone.0037786.g001
Influenza A Virus M1 Oligomerization
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37786Purified M1N protein from affinity chromatography was
exchanged into a buffer of pH 5.0. The protein at the final
concentration of 1.5 mg/ml was loaded onto the gel filtration
column at pH 5.0. Only one fraction of M1N, which eluted at
17.4 ml, was observed (Fig. S3B). This fraction was collected and
concentrated to higher concentration, yet it was still eluted with a
symmetric profile at 17.4 ml (Fig. 3C). Like the intact protein, the
N-terminal domain purified in acidic pH did not oligomerize after
pH neutralization. Only the 17.4-ml fraction appeared on the gel
filtration column after the sample buffer was neutralized to pH 7.4
(Fig. S3D). We also individually collected the 9.8-ml, 11.3-ml, and
13.5-ml fractions from the column at pH 7.4, and transferred
them into a buffer of pH 5.0. Each sample was loaded on the gel
filtration column at pH 5.0, and all the samples eluted at 17.4 ml.
The 17.4-ml fraction generated from acidification of 11.3-ml
fraction was shown in Fig. 3D. These results indicated that the
interactions between M1N were disrupted in an acidic environ-
ment, and moreover, demonstrated that the N-terminal domain
contributes to the pH-dependent oligomerization characteristic of
the intact protein.
To more accurately observe the oligomerization status of M1N,
we also performed sedimentation velocity analytical ultracentrifu-
gation. Unfortunately, due to degradation issues, we could not
resolve the sedimentation coefficient distributions (c(s)) of intact
M1. The M1N samples were collected from a 17.6-ml fraction at
pH 7.4 and a 17.4-ml fraction at pH 5.0 from the gel filtration
column, and then concentrated to 1.2 mg/ml, respectively. The
c(s) value was analyzed accordingly (see materials and methods).
Sedimentation velocity of M1N at pH 5.0 gave rise to a single
peak at 1.8 S (Fig. 4C). This corresponds to a molecular mass of
18.8 kDa (Fig. 4D), which closely agrees with the mass of its
monomeric form. At pH 7.4, the data showed the presence of
three species. The major species was at 1.8 S, and the
sedimentation coefficients of the other two species were 3.5 S
and 5.6 S (Fig. 4A), corresponding to molecular masses of 48 kDa
and 96 kDa (Fig. 4B). No species higher than 100 kDa were
observed. The ascending curve, which appeared at 15.0 S species,
indicated that some of the sample might precipitate during
centrifugation (Fig. 4A). Taken together, we concluded that the
smallest oligomerization state of M1N is a monomer. M1N can
form higher molecular mass oligomers at pH 7.4, but it exists only
in monomeric form at pH 5.0.
To test the self-interaction between N-terminal domains in
solution, we examined their direct binding activity to a panel of
GST fusion proteins. GST-M1 was used to pull down M1N as
GST-M1N was expressed in insoluble form in E. coli. The possible
interaction between M1N and M1C was excluded, as GST-M1
could not pull down M1C. M1N could bind to GST-M1 (Fig. 5A,
lane 3), but not to GST alone at pH 7.4 (Fig. 5A, lane 2). The
result suggested that N-terminal domains can directly interact with
each other at neutral pH. The effect of pH on binding activity was
further examined by incubating GST-beads-bound GST-M1 with
M1N for 2 hours at pH 7.4, and then washing with acidic buffer
(pH 5.0). No M1N was detected by anti-His antibody (Fig. 5A,
lane 4). These data indicated that the direct interactions between
N-terminal domain were disrupted by low pH and confirmed that
oligomerization of N-terminal domain is pH-dependent.
The C-terminal domain is a stable dimer
The C-terminal domain (residues 165–252) of M1 was
expressed as a GST-fusion protein. M1C was purified using
Glutathione Sepharose 4B resin. After cleavage of the GST tag at
the N-terminal by PreScissors protease, the protein migrated as a
single band of about 10 kDa in the PAGE (Fig. S1A). We then
analyzed the oligomerization of M1C with gel filtration. After the
GST tag was removed, M1C was loaded on the gel filtration
column at pH 7.4, yielding a single fraction with an elution
volume of 17.3 ml (Fig. 6A). That fraction was collected,
concentrated and re-applied on the column. Unlike the N-
terminal domain, only one fraction of 17.3 ml eluted on the
column, independent of pH and concentration variations (Fig. 6B).
The apparent molecular mass of the species was calculated to be
Figure 2. Cross-linking assay of M1 and GST pull-down assay detected the direct interaction between M1 molecules. (A) Lane 1 is M1
in the absence of cross-linker, and lane 2 is the cross-linked M1 dimer. (B) Glutathione-Sepharose bound GST-M1 or GST was incubated with hisM1 in
the binding buffer (pH 7.4). After washing extensively with the buffer of different pH (7.4 or 5.0), the hisM1 bound to the beads was extracted and
analyzed by immunoblotting with anti-His antibody.
doi:10.1371/journal.pone.0037786.g002
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theoretical value of monomer (9.7 kDa). Consistent with the gel
filtration result, the 17.3-ml fraction existed as one species with the
diameter of 2.6 nm in dynamic light scatting (DLS) (Fig. S4). No
other oligomers were formed, indicating that the 17.3-ml fraction
is stable and that proteins of this fraction do not interact with each
other.
Sedimentation velocity analytical ultracentrifugation was also
used to analyze the oligomerization states of C-terminal domain
from the accurate molecular mass of protein species. M1C existed
as a mono-disperse species with a sedimentation velocity value of
2.5 S at pH 7.4 (Fig. 6C). This c(s) value corresponds to a
molecular mass of 19.6 kDa (Fig. 6D), indicating that M1C exists
as a stable dimer in solution. The dimeric form of M1C was
further confirmed by cross linking with glutaraldehyde, which
resulted in the 17.3-ml fraction forming two bands on Tricine-
SDS-PAGE. One band was at the same position as the untreated
sample, and the other ran to the position of about 20 kDa, which
is about the molecular mass of an M1C dimer (Fig. 6E). The
molecular mass of M1C obtained by analytical gel filtration is
larger than that obtained by analytical ultracentrifugation, possible
due to its molecular shape. Together, these results indicated that
there is direct interaction between C-terminal domains, and the C-
terminal domain exists in dimeric form.
In the GST pull down assay, no M1C was detected bound to
GST-M1 (Fig. 6F). Combined with the results of the pull down
assay of N-terminal domain, the data suggested that the N-
terminal domain directly binds to the N-terminal domains of other
M1 molecules, while the C-terminal domain forms a stable dimer
that does not interact with other M1 molecules. As a result, we can
conclude that the smallest oligomerization state of M1 is a dimer,
and that dimeric M1 could form higher oligomers through direct
interactions between N-terminal domains.
To further analyze the structural characteristics of the C-
terminal domain, several spectroscopy experiments were also
performed. Far-UV CD spectra of M1C were collected over a
Figure 3. The oligomerization of M1N analyzed by gel filtration. (A) Purified M1N from nickel affinity chromatography yielded five peaks on
Superdex 200. The volumes of elution were indicated. The samples from each peak were collected and analyzed by SDS-PAGE. (B) The 17.6-ml
fraction (from panel A) was collected, concentrated and re-applied to the column at different concentrations, at pH 7.4. (C) Different concentrations
of M1N all eluted as a single peak on the gel filtration column at pH 5.0. (D) Peak 1, 2, 3 correspond to the 9.8-ml, 11.3-ml, and 13.5-ml fractions of
M1N re-applied on the gel filtration column at pH 7.4, respectively. Peak 4 corresponds to the 11.3-ml fraction re-applied on gel filtration column at
pH 5.0.
doi:10.1371/journal.pone.0037786.g003
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pH (data not shown). In all case, nearly identical curves were
obtained, indicating the consistency of the secondary structure in
this domain. The spectrum of M1C showed a clear minimum at
203 nm and a weak minimum at 222 nm. The minimum at
222 nm was indicative of a-helix content, while the minimum at
203 nm could be the result of a combination of a-helix (208 nm)
and random coil structure (200 nm). The exact secondary
structure composition of the three proteins was further analyzed
by DICHROWEB, with the above data converted into mean
molar ellipticity per residue. The results showed that the C-
terminal domain is composed of 31% a-helix and 69% random
coil. Thermal-induced denaturation of M1C measured by
recording ellipticity at 222 nm further revealed the possible
heat-induced conformation change. The data showed a three-
state transition with the apparent presence of intermediate(s)
during denaturation. The two transition points were 32uC and
69uC (Fig. 7B). The content of a-helix was greatly decreased while
that of certain random coil structure was induced with the increase
of temperature. To validate this, M1C was incubated at two
temperature points, and then analyzed by CD (Fig. 7C). At 60uC,
the ellipticity value at 222 nm increased, and the other minimum
moved from 203 nm to 201 nm, both representing the loss of helix
structure. Moreover, the denaturation of M1C was found to be
fully reversible, as almost identical CD spectra were obtained for
native refolded M1C that were cooled from 90uCt o2 5 uC.
To characterize the hydrophobic cluster of M1C, the transfor-
mation of 4,4-Dianilino-1,1-binaphthyl-5,5-disulphonic acid
(ANS) fluorescence spectra was investigated. ANS is a fluorescent
probe that has been widely used to monitor the hydrophobic
exposure of proteins. Fluorescence of ANS is weak in polar
solvents, but is enhanced through the association with exposed
hydrophobic region of proteins. As shown in Fig. 7D, compared to
ANS probe alone, no obvious ANS fluorescence intensity change
was observed when adding dimeric M1C, which suggested that
M1C has a hydrophobic core and that little hydrophobic area was
exposed at 25uC. In contrast, the fluorescence intensity of ANS
was slightly enhanced when M1C was heated at 37uC, and its
emission maximum was blue-shifted. Therefore, this result also
indicated that the hydrophobic core of M1C is exposed to solution
at 37uC, which is higher than the first transition point.
Figure 4. Sedimentation velocity analytical ultracentrifugation determined the oligomerization statue of the N-terminal domain. (A
and C) The panels showed the sedimentation coefficient distributions c(s) of purified M1N from the 17.6-ml fraction at pH 7.4 (A), and from the 17.4-
ml fraction at pH 5.0 (C). The data were acquired at a protein concentration of 1.2 mg/ml. (B and D) The molecular mass distribution derived from c(s)
data of panel A and C, respectively.
doi:10.1371/journal.pone.0037786.g004
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Matrix proteins play a crucial role in virus assembly. They can
interact with the RNP complex, as well as with the viral
membrane. The importance of oligomerization has been observed
in a number of viral matrix proteins. Several examples of this
include: Nipah virus M, which has a tendency to oligomerize [49],
when expressed alone is sufficient to form VLPs [50]; oligomer-
ization of Measles virus M protein can promote the release of
VLPs [51]; the tetrameric form of Borna virus M protein is
reported to be the basic oligomerization species for the assembly of
larger two-dimensional lattices [52]; and oligomerization of Ebola
virus VP40 is essential for particle morphogenesis and regulation
of viral transcription [53].
In influenza A virus particles, Ruigrok et al. reported that M1 is
a 6 nm-long rod [7,41]. It forms an ordered helical layer adjacent
to the envelope in the virus particles [42]. Schulze et al. estimated
that this protein layer was about 60 A ˚ thick [54]. The
oligomerization of M1 has been studied from many aspects. M1
oligomers extracted from the virus were found to form flexible
ribbons and small coils [41]. Furthermore, when M1 alone was
expressed in cells, they found that M1 tends to oligomerize soon
after synthesis [48] and produce VLPs.
In our present study, we investigated the oligomerization of M1
in vitro. Recombinant M1, expressed in soluble form in E. coli, were
able to form multi-ordered oligomers at pH 7.4. We determined
the smallest oligomerization state of M1 to be a dimer, and we
found the oligomerization of M1 to depend on pH. M1 oligomers
were able to disassemble to dimeric form in acidic pH. To our
knowledge, this is the first report on the detection of M1 oligomers
in vitro. Previous studies showed that M1 extracted from the virus
at acidic pH could not oligomerize after pH neutralization [15].
We also identified recombinant M1 purified in vitro at acidic pH
that could also not oligomerize after neutralizing the buffer pH. In
more in-depth studies, we dissected the contributions of the N- and
C-terminal domains to the oligomerization of M1 in detail.
The crystal structure of N-terminal domain solved by Sha and
Harris showed that this domain is in dimeric form [31,32]. But Arz
et al. reported that the N-terminal domain is a monomer in
solution [30]. In our study, we identified that the smallest
oligomerization state of the N-terminal domain is a monomer.
Interaction interfaces between N-terminal domains were observed
in the crystal structure, and Noton et al. reported that the middle
region dominates the oligomerization of M1 [10]. Here, we found
that N-terminal domain can form multi-order oligomers at
pH 7.4, and confirmed the direct interaction between N-terminal
domains. The results indicated that self-oligomerization with the
N-terminal domain is important in the oligomerization of M1.
Further studies showed the oligomerization of N-terminal domain
is pH-dependent. The interaction between N-terminal domains is
disrupted at pH 5.0, causing the oligomers of M1N dissociate to
monomeric form. Moreover, our findings indicated that the N-
terminal domain contributes to the pH-dependence of oligomer-
ization in the intact protein. During the uncoating process of virus
infection, H
+ effluxes from endosomes into virus particles and
acidifies the interior of the virion. Calder et al. found that matrix
layer could disassemble at low pH [42]. The recent studies further
showed the matrix layer would disappear when the virions were
incubated at pH 4.9 for 30 min [47]. Our findings suggest that
dissociation of M1 oligomers may result from the disruption of
interactions in N-terminal domain at low pH. Our data also
showed that the N-terminal domain purified at acidic pH could
not oligomerize after pH neutralization, which may cause the
same phenomenon observed in M1. This result could be related to
the release of vRNP into the nucleus from M1-vRNP complexes,
during which the interaction between M1 and vRNP is destroyed
under acidification [9]. As low pH induces an irreversible
conformation change of M1, it would be unable to re-associate
with vRNP in the cytoplasm [55].
The atomic structure of C-terminal domain has not been
resolved yet. The results of tritium-bombardment experiments
suggest that the C-terminal domain consists largely of a-helix
[33,34,35]. Arzt et al calculated the C-terminal domain to have a
structure consisting of 38% a-helix and considered that C-terminal
domain contributes more size to monomeric intact protein than its
molecular weight [30]. Our DLS data support the view about the
size of the C-terminal domain. The diameter of the C-terminal
domain is 2.6 nm, larger than the global protein with a molecular
mass of 20 kDa (about 2.1 nm). We directly measured the a-helix
content in the C-terminal domain to be 31%, and examined the
structural plasticity by several methods. It has been proposed that
the weakly structured C-terminal domain contributes more to the
flexibility of M1, and considerably unstructured regions enable C-
terminal domain to interact with some components of the host cell
[35,36]. On the other hand, previous research has identified the
important role of the C-terminal domain in virus assembly. Studies
by Noton et al. showed that the N-terminal domain alone is not
sufficient for virion assembly [10]. M1 SUMOylated at K242 has
also been identified to be involved in the process of virus assembly
[56]. The mechanisms of how the C-terminal domain participates
in the oligomerization of M1 reported by Noton et al. [10] and
Ruigrok et al. were inconsistent. Our results disagree with either of
them. In our study, we have demonstrated that the C-terminal
domain is a stable dimer independent of pH and protein
concentration. There is no direct interaction between dimeric
forms of C-terminal domains. Therefore, it is reasonable to infer
that the smallest oligomerization state of M1 is dimer. Our results
also demonstrated that the C-terminal domain does not interact
with the N-terminal domain. Together with the result that the
interaction between N-terminal domains is disrupted at acidic pH,
Figure 5. GST pull-down detected the direct interaction
between N-terminal domains. Glutathione-Sepharose bound GST-
M1 or GST was incubated with M1N in the binding buffer (pH 7.4). After
washing extensively with the buffer of different pH (7.4 or 5.0), the M1N
bound to the beads was extracted and analyzed by immunoblotting
with anti-His antibody.
doi:10.1371/journal.pone.0037786.g005
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37786Figure 6. The characterization of oligomerization of C-terminal domain. (A) After affinity chromatography, purified M1C without the N-
terminal GST tag (affinity), yielded a single peak (1) on a Superdex 200 column. The samples were also analyzed by Tricine-SDS-PAGE. (B) The 17.3-ml
fraction of C-terminal domain from panel A was collected, concentrated and re-applied to gel filtration column. The elution positions of M1C with
different loading concentrations and at different pHs are shown. (C) The panel showed the sedimentation coefficient distributions c(s) of purified M1C
with the concentration of 2.8 mg/ml at pH 7.4. (D) The molecular mass distribution of M1C derived from c(s) data of panel C. (E) Cross-linking of M1C.
Lane 1 is M1C in the absence of cross-linker, and lane 2 is the cross-linked M1C dimer. Lane 3 and 4 are M1N without/with treated by cross linking
agent, respectively. The center lane is the molecular mass marker. (F) Pull-down assay was carried out at pH 7.4. Purified M1C from gel filtration was
bound to GST-beads bound GST-M1 in the binding buffer (pH 7.4). The hisM1 bound with GST-M1 was used as positive control. M1C or hisM1
incubated with GST was used as negative control. The bound M1C were examined by anti-M1 mono-antibody.
doi:10.1371/journal.pone.0037786.g006
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37786leading the N-terminal domain completely dissociates into a
monomer, we conclude that M1 forms a stable dimer at low pH.
In summary, we investigated the oligomerization of M1 of
influenza A virus, and found that the N-terminal domain
contributes to the pH-dependent oligomerization characteristic
of M1. The C-terminal domain is reported for the first time to be a
stable dimer. Both N- and C-terminal domains are involved in the
oligomerization of M1, which is important in the influenza A virus
life cycle. The present data may provide us with new insights into
the mechanism of the formation of matrix layer, and help us to
better understand the dissociation of the matrix layer of influenza
A virus in the uncoating process.
Materials and Methods
Reagents, Escherichia coli strains and antibodies
Escherichia coli (E. coli) strains DH5a and BL21 (DE3) pLysS were
obtained from Novagen. High purity chemicals were purchased
from Sigma-Aldrich. Other suppliers were: DNA polymerase, T4
DNA ligase and restriction enzymes (New England Biolabs);
pET30a vector (Novagen); pGEX-6p-1 vector (GE Healthcare);
Yest Extract and Tryptone needed for Luria-Bertani (LB) media
(Merck); All kits and devices for protein purification (GE
Healthcare); His probe antibody and HRP labeled goat anti-
mouse antibody (Santa Cruz Biotechnology); Chemiluminescent
for Western blot (Pierce). Mouse anti-M1 monoclonal antibody
and rabbit anti-M1 polyclonal antibody were prepared as
described previously [57].
Recombinant plasmids construction
Influenza A virus A/chicken/Jiangsu/1/1998 (H9N2) M1
genes encoding full-length M1 (252 residues) and an N-terminal
fragment (1–170 aa) were amplified by PCR. The amplified DNAs
were purified and digested with NdeI/XhoI enzymes. Then cloned
into the corresponding sites of pET30a vector (Novagen) with a
His6-tag coding sequence (LEHHHHHH) fused at the carboxyl
terminus. Recombinant plasmids pET30a-M1 and pET30a-M1N
were obtained. The purified PCR product of M1C fragment (165–
252 aa) was amplified and cloned into pGEX-6p-1 vector using
BamHI and XhoI restriction sites to obtain recombinant plasmid
pGEX-6P-1-M1C. Plasmids pGEX-6p-1-GST-M1 and pET30a-
hisM1 were also constructed following the similar method. All the
above constructs were transformed into E. coli strain DH5a and
inserted genes were confirmed by DNA sequencing.
Protein expression and purification
Plasmids pET30a-M1, pET30a-M1N, pET30a-hisM1 and
pGEX-6P-1-M1C were transformed into E. coli strain BL21
(DE3) and expressed M1, M1N, hisM1 as His6-tag proteins, while
Figure 7. The structural characteristics of M1C analyzed by CD and Fluorescence Spectroscopy. (A) Secondary structure studies on M1C
at pH 7.4. The CD spectra of M1C at the concentrations of 5 mM (dash dot line), 30 mM (dot line), 60 mM (dash line), and 100 mM (solid line) are shown.
(B) Thermal denaturation of M1C at 60 mM protein concentration was recorded at 222 nm at pH 7.4. (C) Far-UV CD analyses of M1C incubated at
room temperature (solid line), at 37uC for 10 min (dash line), and at 60uC for 10 min (dot line) are shown. (D) Fluorescence spectra of ANS binding to
M1C at pH 7.4. The fluorescence spectra of ANS (dot line), ANS in presence of M1C at 25uC (dash line) and ANS bound with M1C at 37uC (solid line)
are shown.
doi:10.1371/journal.pone.0037786.g007
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grown at 37uC in LB medium containing ampicillin, 100 mg/ml;
kanamycin, 50 mg/ml to an OD600 of 0.8–1.0. The culture was
harvested by centrifugation after induction with 0.5 mM IPTG
(isopropyl-1-thio-b-D-galactopyanoside) at 16uC for 11 h. Then
the cells were resuspended in binding buffer (His6-tagged proteins:
20 mM Tris, 500 mM NaCl, 20 mM imidazole, 0.1 mM PMSF,
pH 7.9; GST-tagged protein: Phosphate buffer saline (PBS),
0.1 mM PMSF, pH 7.4) and lysed by sonication. Insoluble
materials were removed by centrifugation at 13,000 g at 4uC for
20 min. Affinity chromatography was used as the first step of the
purification. Supernatant of M1 and M1N were flowed through a
chelating Sepharose Fast Flow Column, and the bonded proteins
were eluted with elution buffer (20 mM Tris, 500 mM NaCl,
500 mM imidazole pH 7.9). Supernatant of M1C was applied to a
column contained affinity resin (Glutathione Sepharose 4B) and
eluted with elution buffer (50 mM Tris, 50 mM reduced
glutathione, pH 8.0). It was then changed to Cleavage Buffer
(50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM DTT,
pH 7.0), and PreScission Protease and GST-tag were eliminated
by passing through the affinity column twice at 4uC followed by
further purification by gel filtration using A Superdex 200
TM 10/
30 column (10 mm6300 mm) on an A ¨KTA fast protein liquid
chromatography system (FPLC).
Analytical gel filtration analysis
Affinity purified proteins were fractionated by analytical gel
filtration on a Superdex
TM 200 HR 10/30 column
(10 mm6300 mm). The column was equilibrated with two
column of elution buffer before experiment. The process was
executed at a flow rate of 0.5 ml/min at constant room
temperature of 25uC. Absorbance was monitored at 280 nm,
and elution volumes were determined from UV chromatogram.
The column was calibrated with the following standard globular
proteins: Ribonuclease A (13.7 kDa, 18.8 ml), Cyclophilin A
(18.0 kDa, 18.0 ml), Rabbit Action Ovabumin (43 kDa, 16.2 ml),
bovine albumin V (68.0 kDa, 15.1 ml) and Aldolase (158 kDa,
13.3 ml). The void volume of column was determined by Blue
dextran 2000. The partition coefficient, Kav, was calculated from
the elution volume of the sample. A standard calibration curve was
obtained by plotting the ratio (Ve2V0)/(Vt2V0) against the
logarithm of molecular mass (Ve is elution volume, V0 is void
volume and Vt is total bed volume) by UNICORN
TM software.
The apparent molecular mass of the sample can be estimated
based on the acquired straight line.
The determination of proteins oligomerization was performed
by injection of purified proteins from affinity chromatography
onto the gel filtration column at pH 7.4 and pH 5.0. The largest
elution volume fraction of M1 or M1N or M1C on gel filtration
column was collected and concentrated to a series of concentra-
tions in 20 mM Tris, 150 mM NaCl, pH 7.4 or 20 mM sodium
acetate, 150 mM NaCl, pH 5.0 by Ultrafiltration. Then 500 ml
each sample was load onto the column and eluted with the same
buffer to protein solutions.
Analytical ultracentrifugation
Sedimentation velocity was performed in a Beckman-Coulter
XL-I analytical ultracentrifuge. Sample (400 ml) and buffer
(400 ml) solutions were loaded into the double sector centerpiece
separately, and equipped with a four-cell An-60 Tirotor. 1.2 mg/
ml M1N was equilibrated in 20 mM Tris, 150 mM NaCl pH 7.4
and 1.2 mg/ml M1N in 20 mM sodium acetate, 150 mM NaCl,
pH 5.0. 2.8 mg/ml M1C was equilibrated with 20 mM Tris,
150 mM NaCl, pH 7.4. Experiments were carried out with the
rotor speed of 50,000 rpm at 20uC. Scans were monitored at
280 nm with a radial increment step size of 0.003 cm. Differential
sedimentation coefficient distributions, c(s), were calculated by
least squares boundary modeling of sedimentation velocity data
using the c(s) method, which as an implement of SEDFIT program
on www.analyticalultracentrifugation.com/download.htm [58].
The values of apparent sedimentation coefficients (s-values) were
corrected to standard conditions (water, 20uC, and infinite
dilution) using SEDNTERP program (from www.jphilo.mailway.
com/download.htm.) [59], to get the corresponding s-standard
value (s20, w). The frictional coefficients (f/f0) and axial ratios (a/b)
were calculated by using the vbar method in SEDNTERP
program, assuming a prolate ellipsoid model. Sedimentation
coefficient distributions was transformed to a molar mass
distributions based on the frictional ratio [60].
GST pull-down assays
GST pull-down assay was carried out to detect the interactions
in M1 molecules. Expression and purification of hisM1, M1N, and
M1C used in the experiment were followed with the procedure
described above, and purified proteins were exchanged into
binding buffer (20 mM Hepes, 150 mM NaCl, 1 mM EDTA, 1%
NP40, pH 7.4). The GST-M1 or the control GST protein was
expressed in E. coli BL21. Cells were collected and followed by
sonication. The cell lysates were centrifuged at 13,000 g for
15 min at 4uC. The supernatants were applied to a column
containing Glutathione Sepharose 4B binding for 1 h at 4uC [61].
The column was washed with 20 column volumes of PBS. An
equal amount of either GST-M1 or GST bound to affinity resin
was mixed with hisM1 or M1N or M1C in 500 ml binding buffer,
and then incubated for 2 h at 4uC. The resin was washed six times
with washing buffer (300 mM NaCl added in binding buffer,). The
quality of proteins used in the assays as following: 10 mg GST-M1
mixed with 20 mg M1N or M1C or hisM1, 10 mg GST mixed with
20 mg M1N or M1C as negative control. Pull down assay was also
performed to analyze the effect of pH on the binding activity.
10 mg GST-M1 or GST bound to resin was mixed with 20 mg
hisM1 or 20 mg M1N in binding buffer and was washed four times
with washing buffer. Then the resin was washed six times in acidic
environment (20 mM NaH2PO4, 450 mM NaCl, pH 5.0). Pro-
teins bound to the resin were recovered by boiling for 10 min in
presence of 26SDS loading buffer, and subjected to autoradiog-
raphy. Proteins were then detected by Western blot with an anti-
His-tag monoclonal antibody for hisM1, M1N and an anti-M1
monoclonal antibody for M1C.
Glutaraldehyde Cross-linking
Protein cross-linking was performed at room temperature. The
samples were cross-linked with 0.2% (v/v) glutaraldehyde in the
reaction buffer (20 mM sodium phosphate, 100 mM NaCl,
pH 8.0). The reaction mixture was incubated for 5 minutes, and
then the reaction was quenched by adding Tris (1 M, pH 7.5) to a
final concentration of 50 mM. Proteins were analyzed by Tricine-
SDS-PAGE
CD spectroscopy
CD spectra at far-UV (190–260 nm) were performed on a
Jasco810 spectropolarimeter at room temperature (25uC). A 1 mm
quartz cell was used for far-UV CD spectra. M1 and M1N, which
were concentrated to 30 mM by Ultra filtration, were recorded in
50 mM sodium phosphate, pH 7.4. Spectra of 5 mM, 30 mM,
60 mM and 100 mM M1C were measured in 50 mM sodium
phosphate, pH 7.4 and 50 mM NaH2PO4, pH 5.0. The spectra
were collected at a scanning rate of 1 nm/s with intervals of
Influenza A Virus M1 Oligomerization
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and corrected by subtraction of the buffer absorption. The
resulting spectra expressed as mean molar ellipticity per residue.
The secondary structure content was analyzed by DICHROWEB.
Thermal denaturation of M1C was monitored by far-UV CD
spectra at 222 nm in 1 mm path length cell. 30 mM M1C in
50 mM sodium phosphate, pH 7.4 was heated from 4uCt o9 6 uC
at the scan rate of 0.5uC/min. The sample was cooled down to
room temperature immediately when one course complete. The
far-UV CD spectrum of renatured protein was compared with that
of before heating. The final data of thermal denaturation was
averaged by thrice scans.
DLS analysis
The degree of compactness and particle hydrodynamic diam-
eter of M1C was examined by dynamic Light Scattering DLS.
M1C got from on gel filtration column was concentrated to the
optimal reactive concentration of 1.0 mg/ml in 20 mM Tris
(pH 7.4), and then the measurement was performed at 25uC.
Fluorescence Spectroscopy
Fluorescence emission spectra were recorded at room temper-
ature by a HITACHI F-4500 fluorescence spectrophotometer in
1 cm quartz cuvette. ANS binding was detected by fluorescence
spectra at an excitation wavelength of 380 nm. Emission spectra
were measured from 400 nm to 600 nm with the molar ratio
ANS/M1C 100:1. Each spectrum was the average of three
emission scans.
Supporting Information
Figure S1 Expression, purification of M1, M1N, M1C
from E. coli and secondary structure analysis. (A) M1,
M1N and M1C produced in E. coli were purified by affinity
chromatography. The purified proteins were analyzed by Tricine-
SDS-PAGE. Lane M, the molecular mass marker; lane 1, total cell
lysate after induction of pET30a; lane 2, total cell lysate after
induction of pET30a-M1 for 11 h at 16uC; lane 3, purified M1
from nickel affinity chromatography; lane 4, total cell lysate after
pET30a-M1N was induced for 12 h; lane 5, purified M1N from
nickel affinity chromatography; lane 6, total cell lysate of pGEX-
6p-1-M1C prior to induction; lane 7, total cell lysate of pGEX-6p-
1-M1C after induction for 12 h at 16uC; lane 8, GST-M1C eluted
from Glutathione Sepharose 4B; lane 9, M1C yielded by
PreScission protease cleavage of GST-M1C. (B) Far-UV CD
analyses of M1and M1N at the concentration of 30 mM are
shown.
(TIF)
Figure S2 Molecular mass estimation using UNICORN
Software. The apparent molecular masses of the 15.8-ml fraction
of M1, the 17.6-ml fraction of M1N and the 17.3-ml of M1C on
analytical gel filtration column at pH 7.4 were analyzed using
UNICORN Software Analysis Module. The column was calibrat-
ed by a series of standard global proteins, and the correlation of
Log (Molecular weight) and Kav was plotted. The apparent
molecular masses indicated by arrows were calculated from the
straight line.
(TIF)
Figure S3 Gel filtration analyses of neutralized proteins
obtained from acidic pH. (A and B) Purified M1 (A) and M1N
(B) from nickel affinity chromatography were concentrated to 0.7
and 0.6 mg/ml respectively, and loaded on a Superdex 200
column. Purified proteins from the affinity chromatography and
gel filtration were analyzed on SDS-PAGE. (C and D) M1 (C) and
M1N (D) were purified from gel filtration chromatography at
pH 5.0 (solid line), and neutralized into a buffer of pH 7.4,
concentrated and reapplied to the column at pH 7.4 (dot line).
(TIF)
Figure S4 The molecular size of M1C measured by DLS.
The degree of compactness and particle hydrodynamic diameter
of M1C were examined by DLS. Essentially 100% of the
scattering mass was attributed to a single species of M1C.
(TIF)
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